Business Context and Reporting Period
Company: Inmune Bio, Inc. (INMB)
Filing Type: Form 8-K (Current Report)
Date of Report: October 14, 2025
Event: Announcement of CEO participation in an investor conference.
Key Financial Metrics
This filing is a Current Report on Form 8-K regarding a corporate event and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
No material financial changes or operational updates were reported in this document. The filing solely discloses a scheduled public appearance by management.
Guidance, Outlook, and Management Commentary
Management Activity: David Moss, Chief Executive Officer, is scheduled to participate in the Dermatologic Rare Disease Panel at the Maxim Growth Summit.
Event Details: The summit is presented by Maxim Group LLC and will be held on October 22–23, 2025, at the Hard Rock Hotel in New York City.
Outlook: No specific financial guidance or strategic outlook was provided in this filing.
Investor Verification Checklist
- Verify the date and time of the Maxim Growth Summit presentation (October 22–23, 2025).
- Review the press release filed as Exhibit 99.1 for additional context on the CEO's remarks.
- Check subsequent filings (e.g., 10-Q or 10-K) for the most recent financial performance data, as this 8-K contains none.